IP Library › Granted Patent US 10,035,021
Granted Patent B2
US 10,035,021 · App. 15/299,827 · Granted Jul 31, 2018

Use of a new stimulation design to treat neurological disorder

Inventor: Dirk De Ridder (Dunedin, NZ)
A61N1/36196A61B5/0476A61N1/0529A61N1/0551A61N1/361A61N1/36075A61N1/36082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,035,021
App. No.
15/299,827
Granted
Jul 31, 2018
Kind
B2
Abstract

The method and system described herein relate to stimulating nerve tissue using a pulse generator. A stimulus is created that comprises a signal that is produced from a frequency spectrum having a power spectral density per unit of bandwidth proportional to 1/f β , wherein β is excludes 0. The stimulus is provided from the pulse generator to at least one stimulation lead; and applied to nerve tissue via one or several electrodes.

Claims (17)

1. A method of stimulating nerve tissue of a patient using a pulse generator to treat chronic pain of the patient, the method comprising:

generating, by a pulse generator, a set of electrical pulses that exhibit a power spectral density over a first frequency range, wherein (A) the power spectral density of the stimulation therapy generally follows a function of 1/f β , except for power amplitude modulation within a second frequency range more narrow than the first frequency range, (B) β is greater than one (1) and f is a variable representing frequency, (C) the power spectral density is increased by the power amplitude modulation within the second frequency range, (D) the second frequency range includes a peak frequency with a greatest increased power amplitude modulation from power defined by the function of 1/f β , and (E) the peak frequency is within an alpha frequency range of eight (8) to twelve (12) Hertz;

providing the set of electrical pulses from the pulse generator to at least one stimulation lead; and

applying the set of electrical pulses to nerve tissue of the patient via one or several electrodes of the at least one stimulation lead to treat chronic pain of the patient.

2. The method of claim wherein 1 wherein β is selected from values greater than two (2).

3. The method of claim 1 wherein the generating comprises (1) generating a first digital signal, (2) filtering the first digital signal to generate a second digital signal generally following a function of 1/f β , except for increased power amplitude within the second frequency range including the peak frequency, and (3) using the second digital signal to generate the set of electrical pulses.

4. The method of claim 1 further comprising:

automatically detecting a sleep state by the implantable pulse generator; and

automatically modifying a value of β for use by the generating during the sleep state.

5. The method of claim 1 wherein the set of electrical pulses are applied to a spinal cord of the patient.

6. The method of claim 1 wherein the set of electrical pulses are applied to a nerve root ganglion of the patient.

7. The method of claim 1 wherein the set of electrical pulses are applied to a peripheral nerve.

8. The method of claim 1 wherein the applying comprises applying respective pulses of the set of electrical pulses using different electrodes of at least one stimulation lead.

9. The method of claim 8 wherein the different electrodes are selected sequentially.

10. The method of claim 8 wherein the different electrodes are randomly selected.

11. The method of claim 1 further comprising defining an upper frequency bound for the first frequency range.

12. The method of claim 1 further comprising defining a low frequency bound for the first frequency range.

Continuity (4)
Continuation 14176672 · Feb 10, 2014
Continuation 13221548 · Aug 30, 2011
Provisional Application 61378249 · Aug 30, 2010
Related Publication 20170189691A1 · Jul 6, 2017